May 28, 2026
1 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
KIAWAH ISLAND, S.C. — In patients with proliferative diabetic retinopathy, ranibizumab delivered with the Port Delivery System yielded a reduced need for rescue intervention vs. panretinal photocoagulation, according to a presenter. At Kiawah Eye and Retina, Ford Gordon, MD, highlighted a clinical gap in research for the Port Delivery System (Genentech, PDS) as a treatment for proliferative
May 28, 2026
1 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

KIAWAH ISLAND, S.C. — Several treatments are available across the landscape of proliferative diabetic retinopathy, each with…

PHOENIX — A single injection of sura-vec reduced the severity of nonproliferative diabetic retinopathy for up to 2 years,…

DENVER — In a phase 1b trial, subretinal delivery of a human stem cell-derived retinal pigment epithelium yielded visual…

MIAMI — Combining minimally invasive glaucoma surgery with pharmaceutical drug delivery is an option to lower IOP in patients who…

KIAWAH ISLAND, S.C. — Non-stent MIGS devices provided better early IOP reduction and reduced medication use while stent MIGS…

KIAWAH ISLAND, S.C. — Implanting an iStent in combination with phacoemulsification helped reduce IOP in patients with low-tension…